JUPITER, Fla., May 19, 2025 — PICO IV, known for creating the first sterile CBD solution worldwide, which aims to support the endocannabinoid system, participated in the MAHA Spring Gala in Jupiter, Florida, alongside healthcare innovators, wellness experts, and progressive organizations. Hosted by MAHA Action, the event signifies a key moment for the CBD company, reflecting a wider change in perspective regarding natural treatments and CBD’s function in contemporary healthcare.

A Growing Movement for Health Reform

MAHA Action, led by CEO Del Bigtree, is a 501(c)(4) organization and a nationwide initiative focused on addressing the chronic disease crisis. They advocate for increased transparency, informed consent, and public health reforms grounded in scientific evidence. This year’s Spring Gala included prominent figures like Del Bigtree, Alex Clark, and Sayer Ji, along with organic food, live entertainment, and a shared goal for a healthier America.

A Sign of Progress for Natural Therapies

“It was an honor to participate in the MAHA Spring Gala. We’re proud to stand with other innovators dedicated to improving healthcare,” stated Joe Young, CEO and Co-Founder of PICO IV. “The welcoming of a CBD company into this discussion highlights the significant progress in the wellness and healthcare sectors and the direction they are heading.”

Looking Ahead

As MAHA Action continues to unite future healthcare pioneers, PICO IV is pleased to be among those pioneering and providing natural options for the current healthcare environment.

About PICO IV
PICO IV has developed the world’s first sterile CBD solution, created with patent-pending technology and adhering to FDA-approved filtration standards. PICO IV’s main product delivers cannabinoids with exceptional purity and accuracy. More information is available at .

Contact:
Maegan McCarthy Fox

SOURCE PicoIV

“`